KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 55 filers reported holding KALA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,000 | -26.1% | 75,420 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $23,000 | -77.9% | 75,420 | 0.0% | 0.00% | -75.0% |
Q1 2022 | $104,000 | +50.7% | 75,420 | +30.8% | 0.00% | +33.3% |
Q4 2021 | $69,000 | -54.3% | 57,670 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $151,000 | -50.7% | 57,670 | 0.0% | 0.01% | -57.1% |
Q2 2021 | $306,000 | -21.3% | 57,670 | 0.0% | 0.01% | -30.0% |
Q1 2021 | $389,000 | -0.5% | 57,670 | 0.0% | 0.02% | -9.1% |
Q4 2020 | $391,000 | +8.3% | 57,670 | +20.1% | 0.02% | -4.3% |
Q3 2020 | $361,000 | – | 48,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vahanian & Associates Financial Planning Inc. | 181,384 | $54,000 | 0.23% |
Samsara BioCapital, LLC | 601,162 | $180,000 | 0.05% |
Board of Trustees of The Leland Stanford Junior University | 688,701 | $207,000 | 0.01% |
Matisse Capital | 36,800 | $11,000 | 0.01% |
Knights of Columbus Asset Advisors LLC | 120,841 | $36,000 | 0.00% |
Covestor Ltd | 11,972 | $4,000 | 0.00% |
Ergoteles LLC | 219,461 | $66,000 | 0.00% |
Virtu Financial LLC | 74,636 | $22,000 | 0.00% |
IPG Investment Advisors LLC | 14,300 | $4,000 | 0.00% |
Aquatic Capital Management LLC | 13,200 | $4,000 | 0.00% |